Fulltext

LBA-03Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072)

Cunningham, D. ; Langley, R. ; Nankivell, M. ; Blazeby, J. ; Griffin, M. ; Crellin, A. ; Grabsch, H. ; Okines, A. ; Goldstein, C. ; Falk, S. ; Thompson, J. ; Krysztopik, R. ; Coxon, F. ; Pritchard, S. ; Langer, R. ; Stenning, S. ; Alderson, D.

In: Annals of Oncology, 2015, vol. 26, p. iv117-iv118

Aggiungi alla tua lista
    Titre
    • LBA-03Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072)
    Auteur
    • Cunningham, D.. Royal Marsden, London, United Kingdom
    • Langley, R.. MRC Clinical Trials Unit at UCL, London, United Kingdom
    • Nankivell, M.. MRC Clinical Trials Unit at UCL, London, United Kingdom
    • Blazeby, J.. University of Bristol, Bristol, United Kingdom
    • Griffin, M.. Royal Victoria Infirmary, Newcastle, United Kingdom
    • Crellin, A.. St James' Institute of Oncology, Leeds, United Kingdom
    • Grabsch, H.. Leeds Institute of Cancer Studies and Pathology, Leeds, United Kingdom
    • Okines, A.. Royal Marsden, London, United Kingdom
    • Goldstein, C.. MRC Clinical Trials Unit at UCL, London, United Kingdom
    • Falk, S.. University of Bristol, Bristol, United Kingdom
    • Thompson, J.. Birmingham Heartlands Hospital, Birmingham, United Kingdom
    • Krysztopik, R.. Royal United Hospital, Bath, United Kingdom
    • Coxon, F.. Northern Centre for Cancer Care, Newcastle, United Kingdom
    • Pritchard, S.. Wythenshawe Hospital, Manchester, United Kingdom
    • Langer, R.. University of Bern, Bern, Switzerland
    • Stenning, S.. MRC Clinical Trials Unit at UCL, London, United Kingdom
    • Alderson, D.. Queen Elizabeth Hospital, Birmingham, United Kingdom
    Type de document
    • Postprint
    Classification
    • Santé
    Identifiant OAI-PMH
    • oai:doc.rero.ch:299314